Central nervous system pain processing circuits

The "central nervous system pain processing circuits" encompass multiple brain and spinal cord regions and pathways that coordinate the transduction, transmission, modulation, perception, and affective-cognitive appraisal of pain signals. These circuits involve ascending pathways (spinothalamic, spinoparabrachial, spino-amygdalar, and thalamo-cortical tracts), brain regions including the thalamus, amygdala, anterior cingulate cortex, insular cortex, hypothalamus, and descending pain modulatory systems such as those projecting from the periaqueductal gray and rostral ventromedial medulla[1][2][3][4]. The molecular mediators in these circuits include neurotransmitter systems (glutamate, GABA, serotonin, norepinephrine, acetylcholine), ion channels (e.g. Nav1.7, voltage-gated calcium channels), and neuromodulator receptors (opioid, cannabinoid, adrenergic, cholinergic). The circuits are implicated in both acute and chronic pain states and are major research foci for understanding pain pathophysiology and identifying novel analgesic drug targets[1][2][3][5]. They are not a single molecular target but a systems-level entity. This is not a specific molecule or druggable target but a systems neuroscience concept composed of many molecular-level targets, each with their own drugs, mechanisms, and safety profiles[1][2][3][4]. For structured target-based drug discovery, refer to the individual molecular components (e.g., "mu opioid receptor", "Nav1.7 sodium channel", "NMDA receptor") rather than to the entire circuit.

Other names

CNS pain circuitsbrain pain processing circuitscentral pain pathwayspain matrix